In pharma and biotech, you change a validated system only through change control, with documented testing an inspector can review. Replacing an algorithm, a cryptographic library or a certificate authority in a GxP system counts as one of those changes. Signed records also have to stay trustworthy for their whole retention period. An EU clinical trial master file, for example, must be kept for at least 25 years after the trial ends. Regulators and industry bodies set the cryptography for submission gateways and trading-partner credentials, so part of your plan follows their timelines.
Start with the Healthcare overview, which covers pharma, health systems and medical devices. Then send a mixed group to the Pharma Intensive, including someone from quality assurance. The group leaves with a migration plan ready for quality review. Our instructors teach the manufacturing and laboratory sessions from the OT and Critical Infrastructure Extension of the Applied Quantum PQC Migration Framework. No published extension covers GxP validation yet, so the instructors teach it from their own field work.